Jacobs Levy Equity Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
Other funds holding SPPI
AC
ACM
Jacobs Levy Equity Management's SPPI Position: Q4 2022 in Review
Jacobs Levy Equity Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2022, closing a stake of 594,108 shares — an estimated $255K sold.
Jacobs Levy Equity Management first reported a position in SPPI in Q2 2013 and held it in 15 quarters. The position peaked at $4.49M in Q3 2020. 70 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.
- Jacobs Levy Equity Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2022 after selling out during the quarter.
- Jacobs Levy Equity Management sold 594,108 Spectrum Pharmaceuticals Inc shares in Q4 2022, an estimated $255K.
- Jacobs Levy Equity Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
- Jacobs Levy Equity Management's Spectrum Pharmaceuticals Inc position peaked at $4.49M in Q3 2020.
- 70 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2022.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.